Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for Arterial Destiffening in Veterans With Obesity
NCT06745063Phase 2Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- May 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of empagliflozin in obesity, arterial stiffness, sponsored by VA Office of Research & Development. Started May 2025; status: recruiting.
02
Drugs
empagliflozin
03
Conditions
obesityarterial stiffness
Beyond the preview
Go deeper on NCT06745063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06745063.